Literature DB >> 22560007

Ebolavirus vaccines for humans and apes.

Hugues Fausther-Bovendo1, Sabue Mulangu, Nancy J Sullivan.   

Abstract

Because of high case fatality proportions, person-to-person transmission, and potential use in bioterrorism, the development of a vaccine against ebolavirus remains a top priority. Although no licensed vaccine or treatment against ebolavirus is currently available, progress in preclinical testing of countermeasures has been made. Here, we will review ebolavirus vaccine candidates and considerations for their use in humans and wild apes. Published by Elsevier B.V.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22560007      PMCID： PMC3397659          DOI： 10.1016/j.coviro.2012.04.003

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN： 1879-6257            Impact factor:   7.090


  55 in total

1.  Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.

Authors:  Darryl Falzarano; Friederike Feldmann; Allen Grolla; Anders Leung; Hideki Ebihara; James E Strong; Andrea Marzi; Ayato Takada; Shane Jones; Jason Gren; Joan Geisbert; Steven M Jones; Thomas W Geisbert; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

2.  Counting primates for conservation: primate surveys in Uganda.

Authors:  Andrew J Plumptre; Debby Cox
Journal:  Primates       Date:  2005-08-13       Impact factor: 2.163

3.  Photopolymerized hydrogel carriers for live vaccine ballistic delivery.

Authors:  R J Christie; D J Findley; M Dunfee; R D Hansen; S C Olsen; D W Grainger
Journal:  Vaccine       Date:  2005-10-03       Impact factor: 3.641

4.  Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.

Authors:  John M Dye; Andrew S Herbert; Ana I Kuehne; James F Barth; Majidat A Muhammad; Samantha E Zak; Ramon A Ortiz; Laura I Prugar; William D Pratt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

5.  Fruit bats as reservoirs of Ebola virus.

Authors:  Eric M Leroy; Brice Kumulungui; Xavier Pourrut; Pierre Rouquet; Alexandre Hassanin; Philippe Yaba; André Délicat; Janusz T Paweska; Jean-Paul Gonzalez; Robert Swanepoel
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

6.  A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.

Authors:  M Bray; K Davis; T Geisbert; C Schmaljohn; J Huggins
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

7.  Pathogenesis of experimental Ebola virus infection in guinea pigs.

Authors:  B M Connolly; K E Steele; K J Davis; T W Geisbert; W M Kell; N K Jaax; P B Jahrling
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

8.  DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.

Authors:  L Vanderzanden; M Bray; D Fuller; T Roberts; D Custer; K Spik; P Jahrling; J Huggins; A Schmaljohn; C Schmaljohn
Journal:  Virology       Date:  1998-06-20       Impact factor: 3.616

9.  Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species.

Authors:  Stefano Colloca; Eleanor Barnes; Antonella Folgori; Virginia Ammendola; Stefania Capone; Agostino Cirillo; Loredana Siani; Mariarosaria Naddeo; Fabiana Grazioli; Maria Luisa Esposito; Maria Ambrosio; Angela Sparacino; Marta Bartiromo; Annalisa Meola; Kira Smith; Ayako Kurioka; Geraldine A O'Hara; Katie J Ewer; Nicholas Anagnostou; Carly Bliss; Adrian V S Hill; Cinzia Traboni; Paul Klenerman; Riccardo Cortese; Alfredo Nicosia
Journal:  Sci Transl Med       Date:  2012-01-04       Impact factor: 17.956

10.  Consequences of non-intervention for infectious disease in African great apes.

Authors:  Sadie J Ryan; Peter D Walsh
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240
View more
  17 in total

1.  Vaccine-Mediated Induction of an Ebolavirus Cross-Species Antibody Binding to Conserved Epitopes on the Glycoprotein Heptad Repeat 2/Membrane-Proximal External Junction.

Authors:  Alberto Cagigi; Aurélie Ploquin; Thomas Niezold; Yan Zhou; Yaroslav Tsybovsky; John Misasi; Nancy J Sullivan
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

2.  Ebola: facing a new transboundary animal disease?

Authors:  F Feldmann; H Feldmann
Journal:  Dev Biol (Basel)       Date:  2013-05-14

3.  Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine.

Authors:  Jin Huk Choi; Stephen C Schafer; Lihong Zhang; Terry Juelich; Alexander N Freiberg; Maria A Croyle
Journal:  Mol Pharm       Date:  2013-08-19       Impact factor: 4.939

4.  Development of RNA aptamers targeting Ebola virus VP35.

Authors:  Jennifer M Binning; Tianjiao Wang; Priya Luthra; Reed S Shabman; Dominika M Borek; Gai Liu; Wei Xu; Daisy W Leung; Christopher F Basler; Gaya K Amarasinghe
Journal:  Biochemistry       Date:  2013-11-14       Impact factor: 3.162

5.  A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.

Authors:  Katie Ewer; Tommy Rampling; Navin Venkatraman; Georgina Bowyer; Danny Wright; Teresa Lambe; Egeruan B Imoukhuede; Ruth Payne; Sarah Katharina Fehling; Thomas Strecker; Nadine Biedenkopf; Verena Krähling; Claire M Tully; Nick J Edwards; Emma M Bentley; Dhanraj Samuel; Geneviève Labbé; Jing Jin; Malick Gibani; Alice Minhinnick; Morven Wilkie; Ian Poulton; Natalie Lella; Rachel Roberts; Felicity Hartnell; Carly Bliss; Kailan Sierra-Davidson; Jonathan Powlson; Eleanor Berrie; Richard Tedder; Francois Roman; Iris De Ryck; Alfredo Nicosia; Nancy J Sullivan; Daphne A Stanley; Olivier T Mbaya; Julie E Ledgerwood; Richard M Schwartz; Loredana Siani; Stefano Colloca; Antonella Folgori; Stefania Di Marco; Riccardo Cortese; Edward Wright; Stephan Becker; Barney S Graham; Richard A Koup; Myron M Levine; Ariane Volkmann; Paul Chaplin; Andrew J Pollard; Simon J Draper; W Ripley Ballou; Alison Lawrie; Sarah C Gilbert; Adrian V S Hill
Journal:  N Engl J Med       Date:  2015-01-28       Impact factor: 91.245

6.  Efficient extraction of proteins from formalin-fixed paraffin-embedded tissues requires higher concentration of tris(hydroxymethyl)aminomethane.

Authors:  Yusuke Kawashima; Yoshio Kodera; Anil Singh; Masaomi Matsumoto; Hiroyuki Matsumoto
Journal:  Clin Proteomics       Date:  2014-02-01       Impact factor: 3.988

Review 7.  Outbreaks of Ebola virus disease in Africa: the beginnings of a tragic saga.

Authors:  Jean-Philippe Chippaux
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-10-03

8.  A new approach for monitoring ebolavirus in wild great apes.

Authors:  Patricia E Reed; Sabue Mulangu; Kenneth N Cameron; Alain U Ondzie; Damien Joly; Magdalena Bermejo; Pierre Rouquet; Giulia Fabozzi; Michael Bailey; Zhimin Shen; Brandon F Keele; Beatrice Hahn; William B Karesh; Nancy J Sullivan
Journal:  PLoS Negl Trop Dis       Date:  2014-09-18

Review 9.  Novel vaccine strategies against emerging viruses.

Authors:  Adolfo García-Sastre; Ignacio Mena
Journal:  Curr Opin Virol       Date:  2013-03-07       Impact factor: 7.090

10.  Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.

Authors:  Karen A O Martins; Jesse T Steffens; Sean A van Tongeren; Jay B Wells; Alison A Bergeron; Samuel P Dickson; John M Dye; Andres M Salazar; Sina Bavari
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.